Federal contract award
N0003020C0011
FY20 - SP201
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | DCMA SOUTHERN CALIFORNIA |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AC27 — R&D- DEFENSE SYSTEM: MISSILE/SPACE SYSTEMS (COMMERCIALIZED) |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $89.4M |
| Current contract value | $90.0M |
| Potential contract value / ceiling | $90.0M |
| Start date | Nov 1, 2019 |
| Current end date | Sep 30, 2027 |
| Potential end date | Sep 30, 2027 |
| Latest award activity | May 26, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 31 of 31 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 26, 2026 | A00002 | $-569.7K | FY22 - SP201 DE-OBLIGATION OF EXCESS FUNDS UNDER CLINS 0002, 1002, 2002, 2004, 3002, 3004 |
| Feb 4, 2026 | P00028 | $-36.7K | FY22 - SP201 DE-OBLIGATION OF EXCESS FUNDS UNDER CLINS 0002, 1002, 2002, 2004, 3002, 3004 |
| Sep 19, 2025 | P00027 | $6.5M | FY22 - SP201 FULLY FUND CLIN 4004 AND EXTEND POP, EXERCISE OPTION, FULLY FUND, AND EXTEND POP UNDER CLINS 4005 & 4006 |
| Jul 7, 2025 | A00001 | $-3.6K | FY22 - SP201 INC FUND CLIN 4004 |
| Jun 25, 2025 | P00026 | $1.2M | SP28 INC FUND CLIN 4004 |
| Mar 20, 2025 | P00025 | $1.0M | FY22 - SP201 INC FUND CLIN 4004 |
| Feb 5, 2025 | P00024 | $500.0K | FY22 SP201 INC FUND CLIN 4004 |
| Oct 22, 2024 | P00023 | $0 | FY22 SP201 EXTENT POP UNDER CLINS 4001 AND 4003 |
| Sep 9, 2024 | P00022 | $1.0M | FY22 - SP201 INCREMENTAL FUNDING CLIN 4004 |
| Jun 26, 2024 | P00021 | $388.4K | FY22 - SP201 - FULLY FUND CLIN 4002 |
| May 23, 2024 | P00020 | $1.0M | FY22 - SP201 NEW PROCUREMENT MOD ADDING CLINS 4004 - 4006, INCREMENTAL FUNDING OF CLIN 4004, AND ADMINISTRATIVE ACTIONS. |
| Mar 13, 2024 | P00019 | $2.2M | FY22 - SP201 INCREMENTALLY FUND CLIN 4002 IN THE AMOUNT OF $500,000 AND ILOE CLIN 4003 INCREASES OF $1,605,827 TO THE ESTIMATED COST AND $102,878 TO THE FIXED FEE FOR AN INCREASE IN MAN-HOURS OF 2,874. |
| Nov 9, 2023 | P00018 | $14.4M | FY24 OPTION CLINS EXERCISED - 4001 FULLY FUNDED, 4002 INCREMENTALLY FUNDED, AND 4003 FULLY FUNDED. |
| Nov 1, 2023 | P00017 | $0 | EXERCISE OPTION YEAR 4 UNDER CLINS 4001, 4002, AND 4003 |
| Sep 28, 2023 | P00016 | $500.0K | VARIANCE CLIN 3004 |
| Apr 3, 2023 | P00015 | $915.4K | FY22 - SP201 - EXERCISE AND FUND THE 30% CLAUSE ON CLIN3002 IN THE AMOUNT OF $406,345.00 AND EXERCISE AND FUND THE 30% CLAUSE ON CLIN3004 IN THE AMOUNT OF $509,023.00 |
| Feb 3, 2023 | P00014 | $2.2M | FULLY FUNDING FY23 CLINS 3002 AND 3004 |
| Dec 6, 2022 | P00013 | $13.2M | FY23 FUNDING FOR CLINS 3001 AND 3003 - SP201 |
| Oct 28, 2022 | P00012 | $900.0K | FY23 - SP201 |
| Sep 20, 2022 | P00011 | $4.8M | NEW SCOPE - CLINS 2001, 2003, 3001, 3003, 4001, 4003 |
| Aug 1, 2022 | P00010 | $892.9K | FY22 - SP201 |
| May 6, 2022 | P00009 | $1.2M | FY22 - SP201 |
| Mar 11, 2022 | P00008 | $661.5K | FY22 - SP201 |
| Jan 7, 2022 | P00007 | $500.0K | FY22 - SP28 |
| Nov 1, 2021 | P00006 | $11.5M | EO14042 |
| Aug 10, 2021 | P00005 | $1.4M | FY21 - SP201 |
| Apr 13, 2021 | P00004 | $739.5K | FY21 - SP201 |
| Oct 23, 2020 | P00003 | $9.4M | FY21 - SP201 |
| Aug 4, 2020 | P00002 | $-400.0K | FY20 - SP201 |
| Apr 30, 2020 | P00001 | $1.3M | FY20 - SP201 |
| Feb 18, 2020 | 0 | $12.1M | FY20 - SP201 |
Estimated positioning window
Oct 25, 2026 – Mar 30, 2027
65/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 65/100. Available recorded signals: 60 points.
- Contract end 2027-09-30 (340 days from calculation)
- +35 points
- 1 historical awards in this buyer and category group
- +0 points
- 31 recorded award transactions
- +10 points
- Latest award action: 2026-05-26
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.